Ангал® Comb. drug пастилки

Negara: Kirgistan

Bahasa: Rusia

Sumber: Правительства Кыргызской Республики (Департамент лекарственного обеспечения и медицинской техники)

Bahan aktif:

Хлоргексидин + Лидокаин

Tersedia dari:

Лек д.д. (Лек д.д.)

Kode ATC:

R02AA05

INN (Nama Internasional):

Chlorhexidine + Lidocaine

Dosis:

Comb. drug

Bentuk farmasi:

пастилки

Unit dalam paket:

№24

Jenis Resep:

без рецепта

Diproduksi oleh:

Лек Фармасьютикалз д.д. (Словения)

Ringkasan produk:

ПЖВЛС: нет

Tanggal Otorisasi:

2018-03-28

Karakteristik produk

:
YTBEPXAAIO
Ilepnrrfi :auecu.rreJrb
ArrpeKTopa
AenapraMeHTa
JrercapcrBeHHoro
2018
r .
I,THCTPyKUpItI
IIO MEAI,IqI,IHCKOMy IIPI,IME
CPEACTBA
AHIAJI@
i
Topronoe
Ha3BaHrre
AH|AJI@ racrr4rrKr,r
MexgyuapoAHoe
HerrareHToBaHHoe
Ha3BaHlre
Her
(rorvr6r4Hr4poBaHnsrfi
upenapar)
1
Oopnra
Br,rrrycKa
flacrurxu
Onucaulre
Belrte IriIIr norrrrr
6ersre,
B
cJrerKa
B KparrrrHKy,
Kpyurble
ra6uerxu
c apoMaroM
r{ BKycoM
Mrrbr.
Cocras
Oasa nacrurKa
coAepxrdr:
Arcmueuute
6eu4ecm6a: 5
rrar xJropreKcuAr.rHa
Ar4fr{Apoxnoptr4a
Lr
1
nr
nlrAoKauHa
rl4ApoxJIopura.
BcnouozameJrbHbte
6eu4ecm6a:
IreBoMeHToJr,
Jrr{MoHHar
Kr4cJrora
6eseo4uar,
cop6uror, Marnrzs
creapar.
@apuaxorepaleBTrrqecKaq
rpyrr[a
JlerapcrneHHbre npgrraparbr,
nos4eficrByroque Ha
AHTI4CEIITI4KAMU.
Koa
ATX: R02AA
ropno.
Asecreruryr
s
Kor{6r,ruaquu
@apuarco"rroruqecKrre
cnofi
crna
@apuanogrruaMuKa
XlopretccuAl,IH sBrserc{
KarIroHHbrM
luc6uryayr{AHbrM
aHTr.rcerrrr4KoM.
Ou
Aeficrnyer
Ha
rpaMrlonoxplrenbHbre
(Micrococcus
sp.,
Staphylococcus
sp.,
Streptococcus
sp.,
Bacillus
sp.) ra
e
ueutruefi Mepe Ha rpaMorpl{qareJrbHbre
Mr4KpoopraH}r3Mbr,
B
ocHoBHoM
Ha rrx BercTarr4BHyro
Qopuy
(ua
cnopbl rlpn
o6rr.rHrx
reMrreparypax
:He
1eficrnyer).
On
raKxe
o6laAaer
nporLIBoMI4Ko3HbIM
AeficreueNl
B ornorxeHr.rrr
AepMaroSuron
u rpu6ron.
Bucrpo
cHr{xaer
unQuqupyroqyrc
croco6nocrr HeKoropbrx
manoQurmubrx
Br.rpycon
(Hanp.,
Br4pyca
rpunna,
repneca,
BI4r{). B
nugrux
KoHrleHrparlusx
[penapar
4eficrByer
6axrepuocrarr.rqecKu,
a B
BbrcoKr4x
-
6axrepnqr,rAHo.
JIuAoravHa
rl{Apoxnopr4A npercraBnser
co6ofi
nepz(pepnuecxufi
uecrutrfi
aHecrerr,rK
aMu.4HOrO
'tnfra.
oH
oxasHsaeT
rroBepxHocrHoe
aHanbre3r.rpyroqee
BJrr4sHr.re.
OapnrarcorcHHerr{Ka
X,roprencuguu
flpu
nepopaJrbHoM
r,r
MecrHoM
r4crroJrb3oBauuu
a6cop6qug
xlopreKcl{Al,IHa
MaJIa.
XloprexczAr{H
npr,r MecrHoM
rrpr4MeHeHrllr
Ha
HenoBpexAeHnoft
roxe
a6cop6upyercr
no
BHerxgr.re
cJror.r
Koxr{,
uro
o6eclequBaer
AoJIroBpeMeHHoe
rlporl,IBoMllrpo6uoe
4eficrnrae
ua
KOXe.
i ,
XloprercuAr.rH
xopomo
cBs3brBaercs
c
6emaMl{
B
cJIIoHe.
XlopreKcuAI4H
He
HaKaTIJII{Baerct
B
op.u